Company intelligence / Profile preview
Jiangsu Simcere Pharmaceutical Co., Ltd.
Nanjing, Jiangsu, Chinasimcere.com ↗
- Ownership
- Private
- Employees
- ~3000
- Development stage
- Other
01
Overview
Jiangsu Simcere is a leading Chinese pharmaceutical company with a strong focus on R&D-driven innovation. It has six commercialized innovative drugs as of early 2024 and nearly 60 product candidates in its pipeline across oncology, CNS disorders, autoimmunity, and infectious diseases. The company is actively expanding into new therapeutic areas with significant unmet clinical needs. Its modalities span small molecules to advanced biologics such as mAbs and ADCs. Recent clinical progress includes approvals for new therapies in China for COVID antiviral treatment (Simnotrelvir/Ritonavir), non-small cell lung cancer targeted therapies (TGRX‑326), among others.
- Therapeutic areas
- OncologyImmunologyNeurologyInfectious Diseases
- Modalities
- Small moleculesMonoclonal antibodies (mAbs)Bispecific antibodiesMulti-specific antibodiesFusion proteinsAntibody-drug conjugates (ADC)
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
Merck & Co./MSD joint venture for access to key medicines in ChinaTaizhou Mabtech PharmaceuticalShenzhen TargetRx Inc.Strategic alliances with multinational companies for R&D collaboration
Beyond the preview
Go deeper on Jiangsu Simcere Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangsu Simcere Pharmaceutical Co., Ltd..